Hyrimoz and Upper respiratory tract infection - a phase IV clinical study of FDA data

Summary:

Upper respiratory tract infection is reported as a side effect among people who take Hyrimoz (adalimumab-adaz), especially for people who are female, 60+ old, also take Calcium, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Upper respiratory tract infection when taking Hyrimoz. It is created by eHealthMe based on reports of 4,629 people who have side effects when taking Hyrimoz from the FDA, and is updated regularly.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

What is Upper respiratory tract infection?

Upper respiratory tract infection is found to be associated with 1,903 drugs and 1,769 conditions by eHealthMe. Check the latest studies of Upper respiratory tract infection.

On Jul, 07, 2026

4,629 people reported to have side effects when taking Hyrimoz.
Among them, 12 people (0.26%) have Upper respiratory tract infection.

Could Hyrimoz cause Upper respiratory tract infection?

Among these 12 people:

What is the gender of people who have Upper respiratory tract infection when taking Hyrimoz? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Upper respiratory tract infection when taking Hyrimoz? *

What are other drugs people take besides Hyrimoz? *

Xolair: 5 people, 41.67%
Ventolin: 5 people, 41.67%
Singulair: 5 people, 41.67%
Rabeprazole: 5 people, 41.67%
Prednisone: 5 people, 41.67%
Methotrexate: 5 people, 41.67%
Folic Acid: 5 people, 41.67%
Cetirizine Hydrochloride: 5 people, 41.67%
Calcium: 5 people, 41.67%
Vitamin B12: 2 people, 16.67%

What are other side effects people have besides Upper respiratory tract infection? *

Fatigue (feeling of tiredness): 10 people, 83.33%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 66.67%
Injection Site Pain: 7 people, 58.33%
Joint Pain: 7 people, 58.33%
Hypersensitivity: 6 people, 50.00%
Wheezing (a high-pitched whistling sound made while you breath): 5 people, 41.67%
Eye Pruritus (eye itching): 5 people, 41.67%
High Blood Pressure: 5 people, 41.67%
Herpes Zoster: 5 people, 41.67%
Pain In Extremity: 5 people, 41.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 58.33%
Asthma: 5 people, 41.67%
Proctitis (inflammation of the rectum and anus): 2 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 16.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 16.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hyrimoz and have Upper respiratory tract infection?

- Check whether Upper respiratory tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hyrimoz:

Hyrimoz (4,635 reports)

Browse all side effects of Hyrimoz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Upper respiratory tract infection:

Upper respiratory tract infection (1,903 drugs)

Browse all the conditions that are associated with Upper respiratory tract infection:

Upper respiratory tract infection (1,769 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-adaz (the active ingredients of Hyrimoz) and Hyrimoz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.